- Home
- ASTC vs ENSC Comparison
ASTC vs ENSC Comparison
Compare ASTC & ENSC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ASTC
- ENSC
- Stock Information
- Founded
- ASTC 1984
- ENSC 2003
- Country
- ASTC United States
- ENSC United States
- Employees
- ASTC N/A
- ENSC N/A
- Industry
- ASTC Biotechnology: Laboratory Analytical Instruments
- ENSC Biotechnology: Pharmaceutical Preparations
- Sector
- ASTC Industrials
- ENSC Health Care
- Exchange
- ASTC Nasdaq
- ENSC Nasdaq
- Market Cap
- ASTC 7.1M
- ENSC 6.4M
- IPO Year
- ASTC 1995
- ENSC N/A
- Fundamental
- Price
- ASTC $3.33
- ENSC $2.02
- Analyst Decision
- ASTC
- ENSC
- Analyst Count
- ASTC 0
- ENSC 0
- Target Price
- ASTC N/A
- ENSC N/A
- AVG Volume (30 Days)
- ASTC 25.7K
- ENSC 81.4K
- Earning Date
- ASTC 11-13-2025
- ENSC 11-07-2025
- Dividend Yield
- ASTC N/A
- ENSC N/A
- EPS Growth
- ASTC N/A
- ENSC N/A
- EPS
- ASTC N/A
- ENSC N/A
- Revenue
- ASTC $1,049,000.00
- ENSC $7,413,722.00
- Revenue This Year
- ASTC N/A
- ENSC N/A
- Revenue Next Year
- ASTC N/A
- ENSC N/A
- P/E Ratio
- ASTC N/A
- ENSC N/A
- Revenue Growth
- ASTC N/A
- ENSC 415.58
- 52 Week Low
- ASTC $3.07
- ENSC $1.62
- 52 Week High
- ASTC $8.15
- ENSC $12.15
- Technical
- Relative Strength Index (RSI)
- ASTC 34.24
- ENSC 39.36
- Support Level
- ASTC $3.13
- ENSC $2.03
- Resistance Level
- ASTC $4.19
- ENSC $2.14
- Average True Range (ATR)
- ASTC 0.20
- ENSC 0.11
- MACD
- ASTC -0.04
- ENSC -0.02
- Stochastic Oscillator
- ASTC 22.28
- ENSC 26.23
About ASTC Astrotech Corporation (DE)
Astrotech Corp is a science and technology development company. The firm invents, acquires, and commercializes technological innovations sourced from internal research, universities, laboratories, and research institutions. The 1st Detect develops, manufactures, and sells chemical analyzers for use in the airport security, military, and breath analysis markets. AgLAB develops a series of mass spectrometers for use in the agriculture market.
About ENSC Ensysce Biosciences Inc.
Ensysce Biosciences Inc is a clinical-stage biotech company using its proprietary technology platforms to develop safer prescription drugs. The company is developing a new class of powerful, tamper-proof opioids that prevent both drug abuse and overdoses. Its products are anticipated to provide safer options to treat severe pain and assist in preventing deaths caused by opioid abuse, reducing human and economic costs. The company's current development pipeline includes two new drug platforms: an abuse-resistant opioid prodrug technology, theTrypsin Activated Abuse Protection, or the TAAP platform, and an over-dose protection opioid prodrug technology, the Multi-Pill Abuse Resistant, or the MPAR platform. The Company currently operates in one business segment, which is pharmaceuticals.